Timothy P. Noyes, CHIEF EXECUTIVE OFFICER at Aerovate Therapeutics, Inc. (AVTE), sold 20,000 shares at $24.94 ($494K) on 2024-04-16, disclosed to the SEC on 2024-04-18.
Scheduled sale ($494k) by CHIEF EXECUTIVE OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $24.40 | 4,491 | $110K | 22.2% |
| 2 | $24.40 | 4,491 | $110K | 22.2% |
| 3 | $24.94 | 5,509 | $137K | 27.8% |
| 4 | $24.94 | 5,509 | $137K | 27.8% |
| Total | $24.70 avg | 20,000 | $494K | 100% |
| Filing → |
| AVTE | SELL | 2024-04-03 | $519K | — | Filing → |
| AVTE | SELL | 2023-11-03 | $11K | — | Filing → |
| AVTE | SELL | 2023-08-01 | $99K | — | Filing → |